 Data summary          code{white-space: pre;}  pre:not(\[class\]) { background-color: white; }   if (window.hljs) { hljs.configure({languages: \[\]}); hljs.initHighlightingOnLoad(); if (document.readyState && document.readyState === "complete") { window.setTimeout(function() { hljs.initHighlighting(); }, 0); } }   h1 { font-size: 34px; } h1.title { font-size: 38px; } h2 { font-size: 30px; } h3 { font-size: 24px; } h4 { font-size: 18px; } h5 { font-size: 16px; } h6 { font-size: 12px; } .table th:not(\[align\]) { text-align: left; }  .MathJax\_Hover\_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute} .MathJax\_Menu\_Button .MathJax\_Hover\_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0} .MathJax\_Menu\_Button .MathJax\_Hover\_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px} .MathJax\_Hover\_Arrow:hover {color: white!important; border: 2px solid #CCC!important} .MathJax\_Hover\_Arrow:hover span {background-color: #CCC!important} #MathJax\_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')} #MathJax\_About.MathJax\_MousePost {outline: none} .MathJax\_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 2px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')} .MathJax\_MenuItem {padding: 2px 2em; background: transparent} .MathJax\_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em} .MathJax\_MenuActive .MathJax\_MenuArrow {color: white} .MathJax\_MenuArrow.RTL {left: .5em; right: auto} .MathJax\_MenuCheck {position: absolute; left: .7em} .MathJax\_MenuCheck.RTL {right: .7em; left: auto} .MathJax\_MenuRadioCheck {position: absolute; left: 1em} .MathJax\_MenuRadioCheck.RTL {right: 1em; left: auto} .MathJax\_MenuLabel {padding: 2px 2em 4px 1.33em; font-style: italic} .MathJax\_MenuRule {border-top: 1px solid #CCCCCC; margin: 4px 1px 0px} .MathJax\_MenuDisabled {color: GrayText} .MathJax\_MenuActive {background-color: Highlight; color: HighlightText} .MathJax\_MenuDisabled:focus, .MathJax\_MenuLabel:focus {background-color: #E8E8E8} .MathJax\_ContextMenu:focus {outline: none} .MathJax\_ContextMenu .MathJax\_MenuItem:focus {outline: none} #MathJax\_AboutClose {top: .2em; right: .2em} .MathJax\_Menu .MathJax\_MenuClose {top: -10px; left: -10px} .MathJax\_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0} .MathJax\_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px} .MathJax\_MenuClose:hover {color: white!important; border: 2px solid #CCC!important} .MathJax\_MenuClose:hover span {background-color: #CCC!important} .MathJax\_MenuClose:hover:focus {outline: none} .MathJax\_Preview .MJXf-math {color: inherit!important} .MJX\_Assistive\_MathML {position: absolute!important; top: 0; left: 0; clip: rect(1px, 1px, 1px, 1px); padding: 1px 0 0 0!important; border: 0!important; height: 1px!important; width: 1px!important; overflow: hidden!important; display: block!important; -webkit-touch-callout: none; -webkit-user-select: none; -khtml-user-select: none; -moz-user-select: none; -ms-user-select: none; user-select: none} .MJX\_Assistive\_MathML.MJX\_Assistive\_MathML\_Block {width: 100%!important} #MathJax\_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')} #MathJax\_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)} #MathJax\_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0} #MathJax\_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)} .MathJax\_Preview {color: #888} #MathJax\_Message {position: fixed; left: 1em; bottom: 1.5em; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap} #MathJax\_MSIE\_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px} .MathJax\_Error {color: #CC0000; font-style: italic} .MJXp-script {font-size: .8em} .MJXp-right {-webkit-transform-origin: right; -moz-transform-origin: right; -ms-transform-origin: right; -o-transform-origin: right; transform-origin: right} .MJXp-bold {font-weight: bold} .MJXp-italic {font-style: italic} .MJXp-scr {font-family: MathJax\_Script,'Times New Roman',Times,STIXGeneral,serif} .MJXp-frak {font-family: MathJax\_Fraktur,'Times New Roman',Times,STIXGeneral,serif} .MJXp-sf {font-family: MathJax\_SansSerif,'Times New Roman',Times,STIXGeneral,serif} .MJXp-cal {font-family: MathJax\_Caligraphic,'Times New Roman',Times,STIXGeneral,serif} .MJXp-mono {font-family: MathJax\_Typewriter,'Times New Roman',Times,STIXGeneral,serif} .MJXp-largeop {font-size: 150%} .MJXp-largeop.MJXp-int {vertical-align: -.2em} .MJXp-math {display: inline-block; line-height: 1.2; text-indent: 0; font-family: 'Times New Roman',Times,STIXGeneral,serif; white-space: nowrap; border-collapse: collapse} .MJXp-display {display: block; text-align: center; margin: 1em 0} .MJXp-math span {display: inline-block} .MJXp-box {display: block!important; text-align: center} .MJXp-box:after {content: " "} .MJXp-rule {display: block!important; margin-top: .1em} .MJXp-char {display: block!important} .MJXp-mo {margin: 0 .15em} .MJXp-mfrac {margin: 0 .125em; vertical-align: .25em} .MJXp-denom {display: inline-table!important; width: 100%} .MJXp-denom > \* {display: table-row!important} .MJXp-surd {vertical-align: top} .MJXp-surd > \* {display: block!important} .MJXp-script-box > \* {display: table!important; height: 50%} .MJXp-script-box > \* > \* {display: table-cell!important; vertical-align: top} .MJXp-script-box > \*:last-child > \* {vertical-align: bottom} .MJXp-script-box > \* > \* > \* {display: block!important} .MJXp-mphantom {visibility: hidden} .MJXp-munderover {display: inline-table!important} .MJXp-over {display: inline-block!important; text-align: center} .MJXp-over > \* {display: block!important} .MJXp-munderover > \* {display: table-row!important} .MJXp-mtable {vertical-align: .25em; margin: 0 .125em} .MJXp-mtable > \* {display: inline-table!important; vertical-align: middle} .MJXp-mtr {display: table-row!important} .MJXp-mtd {display: table-cell!important; text-align: center; padding: .5em 0 0 .5em} .MJXp-mtr > .MJXp-mtd:first-child {padding-left: 0} .MJXp-mtr:first-child > .MJXp-mtd {padding-top: 0} .MJXp-mlabeledtr {display: table-row!important} .MJXp-mlabeledtr > .MJXp-mtd:first-child {padding-left: 0} .MJXp-mlabeledtr:first-child > .MJXp-mtd {padding-top: 0} .MJXp-merror {background-color: #FFFF88; color: #CC0000; border: 1px solid #CC0000; padding: 1px 3px; font-style: normal; font-size: 90%} .MJXp-scale0 {-webkit-transform: scaleX(.0); -moz-transform: scaleX(.0); -ms-transform: scaleX(.0); -o-transform: scaleX(.0); transform: scaleX(.0)} .MJXp-scale1 {-webkit-transform: scaleX(.1); -moz-transform: scaleX(.1); -ms-transform: scaleX(.1); -o-transform: scaleX(.1); transform: scaleX(.1)} .MJXp-scale2 {-webkit-transform: scaleX(.2); -moz-transform: scaleX(.2); -ms-transform: scaleX(.2); -o-transform: scaleX(.2); transform: scaleX(.2)} .MJXp-scale3 {-webkit-transform: scaleX(.3); -moz-transform: scaleX(.3); -ms-transform: scaleX(.3); -o-transform: scaleX(.3); transform: scaleX(.3)} .MJXp-scale4 {-webkit-transform: scaleX(.4); -moz-transform: scaleX(.4); -ms-transform: scaleX(.4); -o-transform: scaleX(.4); transform: scaleX(.4)} .MJXp-scale5 {-webkit-transform: scaleX(.5); -moz-transform: scaleX(.5); -ms-transform: scaleX(.5); -o-transform: scaleX(.5); transform: scaleX(.5)} .MJXp-scale6 {-webkit-transform: scaleX(.6); -moz-transform: scaleX(.6); -ms-transform: scaleX(.6); -o-transform: scaleX(.6); transform: scaleX(.6)} .MJXp-scale7 {-webkit-transform: scaleX(.7); -moz-transform: scaleX(.7); -ms-transform: scaleX(.7); -o-transform: scaleX(.7); transform: scaleX(.7)} .MJXp-scale8 {-webkit-transform: scaleX(.8); -moz-transform: scaleX(.8); -ms-transform: scaleX(.8); -o-transform: scaleX(.8); transform: scaleX(.8)} .MJXp-scale9 {-webkit-transform: scaleX(.9); -moz-transform: scaleX(.9); -ms-transform: scaleX(.9); -o-transform: scaleX(.9); transform: scaleX(.9)} .MathJax\_PHTML .noError {vertical-align: ; font-size: 90%; text-align: left; color: black; padding: 1px 3px; border: 1px solid} 

.main-container { max-width: 940px; margin-left: auto; margin-right: auto; } code { color: inherit; background-color: rgba(0, 0, 0, 0.04); } img { max-width:100%; height: auto; } .tabbed-pane { padding-top: 12px; } .html-widget { margin-bottom: 20px; } button.code-folding-btn:focus { outline: none; }

$(document).ready(function () { window.buildTabsets("TOC"); });

Data summary
============

#### _Carlos S Traynor_

#### _05/10/2018_

Data charecterisation
---------------------

Here we summarise the general features of the lung squamos cell (LUSC) and colon adenocarcinoma (COAD) TCGA datasets. The data have been downloaded from TCGA and the CBioPortal following these links: LUSC: [http://www.cbioportal.org/study?id=lusc\_tcga#clinical](http://www.cbioportal.org/study?id=lusc_tcga#clinical) COAD: [http://www.cbioportal.org/study?id=coadread\_tcga#summary](http://www.cbioportal.org/study?id=coadread_tcga#summary)

We will use the following libraries:

    if(!require("devtools")) install.packages("devtools")
    if(!require("tidyprojectAZ")) devtools::install_github("tsahota/tidyprojectAZ")
    library(tidyprojectAZ)

Colorectal adenocarcinoma
-------------------------

First we will load the data and make a basic preprocess, to include later the genomic covariates in the model we will filter the clinical dataset for those individuals that also have genomic measurements:

    coad_clinical <- "~/test-data/coadread_tcga/data_bcr_clinical_data_patient.txt"
    convert_blank_to_na <- function(x) {
        if (!purrr::is_character(x)) {
            return(x)
            print("Error not character")
        } else {
            ifelse(x == "" | x == "[Not Available]" | x == "--" | x == 
                "not reported" | x == "[Not Applicable]" | x == "[Discrepancy]", 
                NA, x)
        }
    }
    preprocess_clinical <- function(file) {
        clinical_data <- readr::read_tsv(file, skip = 4)
        # convert variable names to lower case
        colnames(clinical_data) <- tolower(colnames(clinical_data))
        # convert all string NA to NA format
        clinical_data <- clinical_data %>% dplyr::mutate_all(dplyr::funs(convert_blank_to_na))
        clinical_data
    }
    
    coad_clinical <- preprocess_clinical(coad_clinical)
    ## Load patient id all
    match_remove_is_na <- function(x, y) {
        match(x, y)[!is.na(match(x, y))]
    }
    patient_id <- readRDS("~/iClusterPlusUtils/coad/coad_complete_patient_id.RDS")
    coad_clinical <- coad_clinical[match_remove_is_na(patient_id, coad_clinical$patient_id), 
        ]
    dplyr::glimpse(coad_clinical)

    ## Observations: 301
    ## Variables: 64
    ## $ other_patient_id                        <chr> "A94E1279-A975-480A-93...
    ## $ patient_id                              <chr> "TCGA-3L-AA1B", "TCGA-...
    ## $ form_completion_date                    <chr> "4/22/14", "10/1/14", ...
    ## $ histological_diagnosis                  <chr> "Colon Adenocarcinoma"...
    ## $ prospective_collection                  <chr> "YES", "YES", "NO", "N...
    ## $ retrospective_collection                <chr> "NO", "NO", "YES", "YE...
    ## $ sex                                     <chr> "Female", "Male", "Fem...
    ## $ days_to_birth                           <chr> "-22379", "-24523", "-...
    ## $ race                                    <chr> "BLACK OR AFRICAN AMER...
    ## $ ethnicity                               <chr> "NOT HISPANIC OR LATIN...
    ## $ history_other_malignancy                <chr> NA, "No", "No", "No", ...
    ## $ history_neoadjuvant_trtyn               <chr> "No", "No", "No", "No"...
    ## $ initial_pathologic_dx_year              <int> 2013, 2013, 2013, 2009...
    ## $ ajcc_staging_edition                    <chr> "7th", "7th", "7th", "...
    ## $ ajcc_tumor_pathologic_pt                <chr> "T2", "T4a", "T3", "T4...
    ## $ ajcc_nodes_pathologic_pn                <chr> "N0", "N1b", "N0", "N2...
    ## $ ajcc_metastasis_pathologic_pm           <chr> "M0", "M0", "MX", "M1a...
    ## $ ajcc_pathologic_tumor_stage             <chr> "Stage I", "Stage IIIB...
    ## $ residual_tumor                          <chr> "R0", "R0", "R0", "R2"...
    ## $ lymph_nodes_examined                    <chr> "YES", "YES", "YES", "...
    ## $ lymph_node_examined_count               <chr> "28", "25", "24", "11"...
    ## $ lymph_nodes_examined_he_count           <chr> "0", NA, "0", "10", "0...
    ## $ lymph_nodes_examined_ihc_count          <chr> "0", "2", NA, "0", NA,...
    ## $ vital_status                            <chr> "Alive", "Alive", "Ali...
    ## $ days_to_last_followup                   <chr> "154", "8", "160", NA,...
    ## $ days_to_death                           <chr> NA, NA, NA, "290", NA,...
    ## $ tumor_status                            <chr> "TUMOR FREE", "WITH TU...
    ## $ vascular_invasion_indicator             <chr> "NO", "NO", "NO", "YES...
    ## $ lymphovascular_invasion_indicator       <chr> "NO", "NO", "NO", "YES...
    ## $ perineural_invasion                     <chr> "NO", "NO", "NO", "YES...
    ## $ kras_gene_analysis_indicator            <chr> "NO", "NO", "NO", "NO"...
    ## $ kras_mutation                           <chr> NA, NA, NA, NA, NA, NA...
    ## $ braf_gene_analysis_indicator            <chr> "NO", "NO", "NO", NA, ...
    ## $ braf_gene_analysis_result               <chr> NA, NA, NA, NA, NA, NA...
    ## $ weight                                  <chr> "63.3", "134", "107.95...
    ## $ height                                  <chr> "173", "167.64", "167....
    ## $ radiation_treatment_adjuvant            <chr> NA, "NO", "NO", "NO", ...
    ## $ pharmaceutical_tx_adjuvant              <chr> NA, "YES", "NO", "YES"...
    ## $ treatment_outcome_first_course          <chr> "Complete Remission/Re...
    ## $ new_tumor_event_after_initial_treatment <chr> "NO", "NO", "NO", "YES...
    ## $ age                                     <int> 61, 67, 42, 40, 75, 48...
    ## $ primary_site                            <chr> "Cecum", "Ascending Co...
    ## $ clin_m_stage                            <lgl> NA, NA, NA, NA, NA, NA...
    ## $ clin_n_stage                            <lgl> NA, NA, NA, NA, NA, NA...
    ## $ clin_t_stage                            <lgl> NA, NA, NA, NA, NA, NA...
    ## $ clinical_stage                          <lgl> NA, NA, NA, NA, NA, NA...
    ## $ days_to_initial_pathologic_diagnosis    <int> 0, 0, 0, 0, 0, 0, 0, 0...
    ## $ days_to_patient_progression_free        <lgl> NA, NA, NA, NA, NA, NA...
    ## $ days_to_tumor_progression               <lgl> NA, NA, NA, NA, NA, NA...
    ## $ disease_code                            <chr> NA, NA, NA, NA, "FPPP"...
    ## $ extranodal_involvement                  <lgl> NA, NA, NA, NA, NA, NA...
    ## $ icd_10                                  <chr> "C18.0", "C18.2", "C18...
    ## $ icd_o_3_histology                       <chr> "8140/3", "8140/3", "8...
    ## $ icd_o_3_site                            <chr> "C18.0", "C18.2", "C18...
    ## $ informed_consent_verified               <chr> "YES", "YES", "YES", "...
    ## $ initial_pathologic_diagnosis_method     <lgl> NA, NA, NA, NA, NA, NA...
    ## $ project_code                            <chr> NA, NA, NA, NA, "TCGA"...
    ## $ stage_other                             <lgl> NA, NA, NA, NA, NA, NA...
    ## $ tissue_source_site                      <chr> "3L", "4N", "4T", "5M"...
    ## $ tumor_tissue_site                       <chr> "Colon", "Colon", "Col...
    ## $ os_status                               <chr> NA, "LIVING", "LIVING"...
    ## $ os_months                               <chr> NA, "4.8", "12.65", "9...
    ## $ dfs_status                              <chr> NA, "DiseaseFree", "Di...
    ## $ dfs_months                              <chr> NA, "4.8", "12.65", "7...

In the tidy description of the dataset obtained with glimpse we see that we have covariates that may potentially be used as treatment effect : - pharmaceutical\_tx\_adjuvant - radiation\_treatment\_adjuvan - history\_neoadjuvant\_trtyn

Then we have variables that may be considered secondary outcome and potentially joint modelled with the overall survival: - treatment\_outcome\_first\_course - new\_tumor\_event\_after\_initial\_treatment - dfs\_status - dfs\_months

We can visualise the missing values of these variables with the VIM package:

    coad_clinical %>% dplyr::select(tx = pharmaceutical_tx_adjuvant, 
        rad_tx = radiation_treatment_adjuvant, tx_out = treatment_outcome_first_course, 
        recurred = new_tumor_event_after_initial_treatment, h_neo = history_neoadjuvant_trtyn, 
        dfs_status, dfs_t = dfs_months) %>% VIM::aggr(prop = T, labels = colnames(.), 
        numbers = TRUE)

![](data:image/png;base64,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<!DOCTYPE html>
<!-- saved from url=(0113)https://rstudio.scp.astrazeneca.net/s/2ed51cfc78a31a4e732f2/files/iClusterPlusUtils/vignettes/datapreprocess.html -->
<html xmlns=)    Data summary          code{white-space: pre;}  pre:not(\[class\]) { background-color: white; }   if (window.hljs) { hljs.configure({languages: \[\]}); hljs.initHighlightingOnLoad(); if (document.readyState && document.readyState === "complete") { window.setTimeout(function() { hljs.initHighlighting(); }, 0); } }   h1 { font-size: 34px; } h1.title { font-size: 38px; } h2 { font-size: 30px; } h3 { font-size: 24px; } h4 { font-size: 18px; } h5 { font-size: 16px; } h6 { font-size: 12px; } .table th:not(\[align\]) { text-align: left; }  .MathJax\_Hover\_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute} .MathJax\_Menu\_Button .MathJax\_Hover\_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0} .MathJax\_Menu\_Button .MathJax\_Hover\_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px} .MathJax\_Hover\_Arrow:hover {color: white!important; border: 2px solid #CCC!important} .MathJax\_Hover\_Arrow:hover span {background-color: #CCC!important} #MathJax\_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')} #MathJax\_About.MathJax\_MousePost {outline: none} .MathJax\_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 2px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')} .MathJax\_MenuItem {padding: 2px 2em; background: transparent} .MathJax\_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em} .MathJax\_MenuActive .MathJax\_MenuArrow {color: white} .MathJax\_MenuArrow.RTL {left: .5em; right: auto} .MathJax\_MenuCheck {position: absolute; left: .7em} .MathJax\_MenuCheck.RTL {right: .7em; left: auto} .MathJax\_MenuRadioCheck {position: absolute; left: 1em} .MathJax\_MenuRadioCheck.RTL {right: 1em; left: auto} .MathJax\_MenuLabel {padding: 2px 2em 4px 1.33em; font-style: italic} .MathJax\_MenuRule {border-top: 1px solid #CCCCCC; margin: 4px 1px 0px} .MathJax\_MenuDisabled {color: GrayText} .MathJax\_MenuActive {background-color: Highlight; color: HighlightText} .MathJax\_MenuDisabled:focus, .MathJax\_MenuLabel:focus {background-color: #E8E8E8} .MathJax\_ContextMenu:focus {outline: none} .MathJax\_ContextMenu .MathJax\_MenuItem:focus {outline: none} #MathJax\_AboutClose {top: .2em; right: .2em} .MathJax\_Menu .MathJax\_MenuClose {top: -10px; left: -10px} .MathJax\_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0} .MathJax\_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px} .MathJax\_MenuClose:hover {color: white!important; border: 2px solid #CCC!important} .MathJax\_MenuClose:hover span {background-color: #CCC!important} .MathJax\_MenuClose:hover:focus {outline: none} .MathJax\_Preview .MJXf-math {color: inherit!important} .MJX\_Assistive\_MathML {position: absolute!important; top: 0; left: 0; clip: rect(1px, 1px, 1px, 1px); padding: 1px 0 0 0!important; border: 0!important; height: 1px!important; width: 1px!important; overflow: hidden!important; display: block!important; -webkit-touch-callout: none; -webkit-user-select: none; -khtml-user-select: none; -moz-user-select: none; -ms-user-select: none; user-select: none} .MJX\_Assistive\_MathML.MJX\_Assistive\_MathML\_Block {width: 100%!important} #MathJax\_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')} #MathJax\_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)} #MathJax\_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0} #MathJax\_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)} .MathJax\_Preview {color: #888} #MathJax\_Message {position: fixed; left: 1em; bottom: 1.5em; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap} #MathJax\_MSIE\_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px} .MathJax\_Error {color: #CC0000; font-style: italic} .MJXp-script {font-size: .8em} .MJXp-right {-webkit-transform-origin: right; -moz-transform-origin: right; -ms-transform-origin: right; -o-transform-origin: right; transform-origin: right} .MJXp-bold {font-weight: bold} .MJXp-italic {font-style: italic} .MJXp-scr {font-family: MathJax\_Script,'Times New Roman',Times,STIXGeneral,serif} .MJXp-frak {font-family: MathJax\_Fraktur,'Times New Roman',Times,STIXGeneral,serif} .MJXp-sf {font-family: MathJax\_SansSerif,'Times New Roman',Times,STIXGeneral,serif} .MJXp-cal {font-family: MathJax\_Caligraphic,'Times New Roman',Times,STIXGeneral,serif} .MJXp-mono {font-family: MathJax\_Typewriter,'Times New Roman',Times,STIXGeneral,serif} .MJXp-largeop {font-size: 150%} .MJXp-largeop.MJXp-int {vertical-align: -.2em} .MJXp-math {display: inline-block; line-height: 1.2; text-indent: 0; font-family: 'Times New Roman',Times,STIXGeneral,serif; white-space: nowrap; border-collapse: collapse} .MJXp-display {display: block; text-align: center; margin: 1em 0} .MJXp-math span {display: inline-block} .MJXp-box {display: block!important; text-align: center} .MJXp-box:after {content: " "} .MJXp-rule {display: block!important; margin-top: .1em} .MJXp-char {display: block!important} .MJXp-mo {margin: 0 .15em} .MJXp-mfrac {margin: 0 .125em; vertical-align: .25em} .MJXp-denom {display: inline-table!important; width: 100%} .MJXp-denom > \* {display: table-row!important} .MJXp-surd {vertical-align: top} .MJXp-surd > \* {display: block!important} .MJXp-script-box > \* {display: table!important; height: 50%} .MJXp-script-box > \* > \* {display: table-cell!important; vertical-align: top} .MJXp-script-box > \*:last-child > \* {vertical-align: bottom} .MJXp-script-box > \* > \* > \* {display: block!important} .MJXp-mphantom {visibility: hidden} .MJXp-munderover {display: inline-table!important} .MJXp-over {display: inline-block!important; text-align: center} .MJXp-over > \* {display: block!important} .MJXp-munderover > \* {display: table-row!important} .MJXp-mtable {vertical-align: .25em; margin: 0 .125em} .MJXp-mtable > \* {display: inline-table!important; vertical-align: middle} .MJXp-mtr {display: table-row!important} .MJXp-mtd {display: table-cell!important; text-align: center; padding: .5em 0 0 .5em} .MJXp-mtr > .MJXp-mtd:first-child {padding-left: 0} .MJXp-mtr:first-child > .MJXp-mtd {padding-top: 0} .MJXp-mlabeledtr {display: table-row!important} .MJXp-mlabeledtr > .MJXp-mtd:first-child {padding-left: 0} .MJXp-mlabeledtr:first-child > .MJXp-mtd {padding-top: 0} .MJXp-merror {background-color: #FFFF88; color: #CC0000; border: 1px solid #CC0000; padding: 1px 3px; font-style: normal; font-size: 90%} .MJXp-scale0 {-webkit-transform: scaleX(.0); -moz-transform: scaleX(.0); -ms-transform: scaleX(.0); -o-transform: scaleX(.0); transform: scaleX(.0)} .MJXp-scale1 {-webkit-transform: scaleX(.1); -moz-transform: scaleX(.1); -ms-transform: scaleX(.1); -o-transform: scaleX(.1); transform: scaleX(.1)} .MJXp-scale2 {-webkit-transform: scaleX(.2); -moz-transform: scaleX(.2); -ms-transform: scaleX(.2); -o-transform: scaleX(.2); transform: scaleX(.2)} .MJXp-scale3 {-webkit-transform: scaleX(.3); -moz-transform: scaleX(.3); -ms-transform: scaleX(.3); -o-transform: scaleX(.3); transform: scaleX(.3)} .MJXp-scale4 {-webkit-transform: scaleX(.4); -moz-transform: scaleX(.4); -ms-transform: scaleX(.4); -o-transform: scaleX(.4); transform: scaleX(.4)} .MJXp-scale5 {-webkit-transform: scaleX(.5); -moz-transform: scaleX(.5); -ms-transform: scaleX(.5); -o-transform: scaleX(.5); transform: scaleX(.5)} .MJXp-scale6 {-webkit-transform: scaleX(.6); -moz-transform: scaleX(.6); -ms-transform: scaleX(.6); -o-transform: scaleX(.6); transform: scaleX(.6)} .MJXp-scale7 {-webkit-transform: scaleX(.7); -moz-transform: scaleX(.7); -ms-transform: scaleX(.7); -o-transform: scaleX(.7); transform: scaleX(.7)} .MJXp-scale8 {-webkit-transform: scaleX(.8); -moz-transform: scaleX(.8); -ms-transform: scaleX(.8); -o-transform: scaleX(.8); transform: scaleX(.8)} .MJXp-scale9 {-webkit-transform: scaleX(.9); -moz-transform: scaleX(.9); -ms-transform: scaleX(.9); -o-transform: scaleX(.9); transform: scaleX(.9)} .MathJax\_PHTML .noError {vertical-align: ; font-size: 90%; text-align: left; color: black; padding: 1px 3px; border: 1px solid} 

.main-container { max-width: 940px; margin-left: auto; margin-right: auto; } code { color: inherit; background-color: rgba(0, 0, 0, 0.04); } img { max-width:100%; height: auto; } .tabbed-pane { padding-top: 12px; } .html-widget { margin-bottom: 20px; } button.code-folding-btn:focus { outline: none; }

$(document).ready(function () { window.buildTabsets("TOC"); });

Data summary
============

#### _Carlos S Traynor_

#### _05/10/2018_

Data charecterisation
---------------------

Here we summarise the general features of the lung squamos cell (LUSC) and colon adenocarcinoma (COAD) TCGA datasets. The data have been downloaded from TCGA and the CBioPortal following these links: LUSC: [http://www.cbioportal.org/study?id=lusc\_tcga#clinical](http://www.cbioportal.org/study?id=lusc_tcga#clinical) COAD: [http://www.cbioportal.org/study?id=coadread\_tcga#summary](http://www.cbioportal.org/study?id=coadread_tcga#summary)

We will use the following libraries:

    if(!require("devtools")) install.packages("devtools")
    if(!require("tidyprojectAZ")) devtools::install_github("tsahota/tidyprojectAZ")
    library(tidyprojectAZ)

Colorectal adenocarcinoma
-------------------------

First we will load the data and make a basic preprocess, to include later the genomic covariates in the model we will filter the clinical dataset for those individuals that also have genomic measurements:

    coad_clinical <- "~/test-data/coadread_tcga/data_bcr_clinical_data_patient.txt"
    convert_blank_to_na <- function(x) {
        if (!purrr::is_character(x)) {
            return(x)
            print("Error not character")
        } else {
            ifelse(x == "" | x == "[Not Available]" | x == "--" | x == 
                "not reported" | x == "[Not Applicable]" | x == "[Discrepancy]", 
                NA, x)
        }
    }
    preprocess_clinical <- function(file) {
        clinical_data <- readr::read_tsv(file, skip = 4)
        # convert variable names to lower case
        colnames(clinical_data) <- tolower(colnames(clinical_data))
        # convert all string NA to NA format
        clinical_data <- clinical_data %>% dplyr::mutate_all(dplyr::funs(convert_blank_to_na))
        clinical_data
    }
    
    coad_clinical <- preprocess_clinical(coad_clinical)
    ## Load patient id all
    match_remove_is_na <- function(x, y) {
        match(x, y)[!is.na(match(x, y))]
    }
    patient_id <- readRDS("~/iClusterPlusUtils/coad/coad_complete_patient_id.RDS")
    coad_clinical <- coad_clinical[match_remove_is_na(patient_id, coad_clinical$patient_id), 
        ]
    dplyr::glimpse(coad_clinical)

    ## Observations: 301
    ## Variables: 64
    ## $ other_patient_id                        <chr> "A94E1279-A975-480A-93...
    ## $ patient_id                              <chr> "TCGA-3L-AA1B", "TCGA-...
    ## $ form_completion_date                    <chr> "4/22/14", "10/1/14", ...
    ## $ histological_diagnosis                  <chr> "Colon Adenocarcinoma"...
    ## $ prospective_collection                  <chr> "YES", "YES", "NO", "N...
    ## $ retrospective_collection                <chr> "NO", "NO", "YES", "YE...
    ## $ sex                                     <chr> "Female", "Male", "Fem...
    ## $ days_to_birth                           <chr> "-22379", "-24523", "-...
    ## $ race                                    <chr> "BLACK OR AFRICAN AMER...
    ## $ ethnicity                               <chr> "NOT HISPANIC OR LATIN...
    ## $ history_other_malignancy                <chr> NA, "No", "No", "No", ...
    ## $ history_neoadjuvant_trtyn               <chr> "No", "No", "No", "No"...
    ## $ initial_pathologic_dx_year              <int> 2013, 2013, 2013, 2009...
    ## $ ajcc_staging_edition                    <chr> "7th", "7th", "7th", "...
    ## $ ajcc_tumor_pathologic_pt                <chr> "T2", "T4a", "T3", "T4...
    ## $ ajcc_nodes_pathologic_pn                <chr> "N0", "N1b", "N0", "N2...
    ## $ ajcc_metastasis_pathologic_pm           <chr> "M0", "M0", "MX", "M1a...
    ## $ ajcc_pathologic_tumor_stage             <chr> "Stage I", "Stage IIIB...
    ## $ residual_tumor                          <chr> "R0", "R0", "R0", "R2"...
    ## $ lymph_nodes_examined                    <chr> "YES", "YES", "YES", "...
    ## $ lymph_node_examined_count               <chr> "28", "25", "24", "11"...
    ## $ lymph_nodes_examined_he_count           <chr> "0", NA, "0", "10", "0...
    ## $ lymph_nodes_examined_ihc_count          <chr> "0", "2", NA, "0", NA,...
    ## $ vital_status                            <chr> "Alive", "Alive", "Ali...
    ## $ days_to_last_followup                   <chr> "154", "8", "160", NA,...
    ## $ days_to_death                           <chr> NA, NA, NA, "290", NA,...
    ## $ tumor_status                            <chr> "TUMOR FREE", "WITH TU...
    ## $ vascular_invasion_indicator             <chr> "NO", "NO", "NO", "YES...
    ## $ lymphovascular_invasion_indicator       <chr> "NO", "NO", "NO", "YES...
    ## $ perineural_invasion                     <chr> "NO", "NO", "NO", "YES...
    ## $ kras_gene_analysis_indicator            <chr> "NO", "NO", "NO", "NO"...
    ## $ kras_mutation                           <chr> NA, NA, NA, NA, NA, NA...
    ## $ braf_gene_analysis_indicator            <chr> "NO", "NO", "NO", NA, ...
    ## $ braf_gene_analysis_result               <chr> NA, NA, NA, NA, NA, NA...
    ## $ weight                                  <chr> "63.3", "134", "107.95...
    ## $ height                                  <chr> "173", "167.64", "167....
    ## $ radiation_treatment_adjuvant            <chr> NA, "NO", "NO", "NO", ...
    ## $ pharmaceutical_tx_adjuvant              <chr> NA, "YES", "NO", "YES"...
    ## $ treatment_outcome_first_course          <chr> "Complete Remission/Re...
    ## $ new_tumor_event_after_initial_treatment <chr> "NO", "NO", "NO", "YES...
    ## $ age                                     <int> 61, 67, 42, 40, 75, 48...
    ## $ primary_site                            <chr> "Cecum", "Ascending Co...
    ## $ clin_m_stage                            <lgl> NA, NA, NA, NA, NA, NA...
    ## $ clin_n_stage                            <lgl> NA, NA, NA, NA, NA, NA...
    ## $ clin_t_stage                            <lgl> NA, NA, NA, NA, NA, NA...
    ## $ clinical_stage                          <lgl> NA, NA, NA, NA, NA, NA...
    ## $ days_to_initial_pathologic_diagnosis    <int> 0, 0, 0, 0, 0, 0, 0, 0...
    ## $ days_to_patient_progression_free        <lgl> NA, NA, NA, NA, NA, NA...
    ## $ days_to_tumor_progression               <lgl> NA, NA, NA, NA, NA, NA...
    ## $ disease_code                            <chr> NA, NA, NA, NA, "FPPP"...
    ## $ extranodal_involvement                  <lgl> NA, NA, NA, NA, NA, NA...
    ## $ icd_10                                  <chr> "C18.0", "C18.2", "C18...
    ## $ icd_o_3_histology                       <chr> "8140/3", "8140/3", "8...
    ## $ icd_o_3_site                            <chr> "C18.0", "C18.2", "C18...
    ## $ informed_consent_verified               <chr> "YES", "YES", "YES", "...
    ## $ initial_pathologic_diagnosis_method     <lgl> NA, NA, NA, NA, NA, NA...
    ## $ project_code                            <chr> NA, NA, NA, NA, "TCGA"...
    ## $ stage_other                             <lgl> NA, NA, NA, NA, NA, NA...
    ## $ tissue_source_site                      <chr> "3L", "4N", "4T", "5M"...
    ## $ tumor_tissue_site                       <chr> "Colon", "Colon", "Col...
    ## $ os_status                               <chr> NA, "LIVING", "LIVING"...
    ## $ os_months                               <chr> NA, "4.8", "12.65", "9...
    ## $ dfs_status                              <chr> NA, "DiseaseFree", "Di...
    ## $ dfs_months                              <chr> NA, "4.8", "12.65", "7...

In the tidy description of the dataset obtained with glimpse we see that we have covariates that may potentially be used as treatment effect : - pharmaceutical\_tx\_adjuvant - radiation\_treatment\_adjuvan - history\_neoadjuvant\_trtyn

Then we have variables that may be considered secondary outcome and potentially joint modelled with the overall survival: - treatment\_outcome\_first\_course - new\_tumor\_event\_after\_initial\_treatment - dfs\_status - dfs\_months

We can visualise the missing values of these variables with the VIM package:

    coad_clinical %>% dplyr::select(tx = pharmaceutical_tx_adjuvant, 
        rad_tx = radiation_treatment_adjuvant, tx_out = treatment_outcome_first_course, 
        recurred = new_tumor_event_after_initial_treatment, h_neo = history_neoadjuvant_trtyn, 
        dfs_status, dfs_t = dfs_months) %>% VIM::aggr(prop = T, labels = colnames(.), 
        numbers = TRUE)
